BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Hutson, D.O.
Hoosier Cancer Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
108 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital: Sydney Cancer Centre
Camperdown, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Sydney Adventist Hospital Ltd.
Wahroonga, New South Wales, Australia
- Gallipoli Medical Research Foundation: Greenslopes Private Hospital
Greenslopes, Queensland, Australia
- Royal Brisbane & Women'S Hospital
Herston, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Ashford Cancer Centre
Kurralta Park, South Australia, Australia
- Gallipoli Medical Research Foundation: Launceston General Hospital
Launceston, Tasmania, Australia
- Peninsula Oncology Centre
Frankston, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Alfred Hospital
Melbourne, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- National Cancer Centre Singapore
Singapore, Singapore
- Northwest Alabama Cancer Center
Muscle Shoals, Alabama, United States
- Genesis Cancer Center
Hot Springs, Arkansas, United States
- Providence Health System: Roy and Patricia Disney Family Cancer Center
Burbank, California, United States
- Compassionate Cancer Care Medical Group
Corona, California, United States
- Compassionate Cancer Care Medical Group, Inc.
Corona, California, United States
- City of Hope
Duarte, California, United States
- Robert A. Moss, M.D., Facp, Inc.
Fountain Valley, California, United States
- California Cancer Associates for Research and Excellence
Fresno, California, United States
- Marin Specialty Care
Greenbrae, California, United States
- Good Samaritan Hospital
Los Angeles, California, United States
- Ucla Med - Hematology & Oncology
Los Angeles, California, United States
- Compassionate Cancer Care Medical Group
Riverside, California, United States
- American Institute of Research
Whittier, California, United States
- Centura Health Research Center
Denver, Colorado, United States
- Western Oncology & Hematology
Golden, Colorado, United States
- Cancer Care Centers of Florida: Brooksville
Brooksville, Florida, United States
- Broward Oncology Associates
Fort Lauderdale, Florida, United States
- University of Florida, Shands Cancer Center
Gainesville, Florida, United States
- Cancer Specialists of North Florida
Jacksonville, Florida, United States
- Advanced Pharma Cr, Llc
Miami, Florida, United States
- Cancer Care Centers of Florida
New Port Richey, Florida, United States
- Ocala Cancer Institute
Ocala, Florida, United States
- Cancer Care Centers of Brevard
Rockledge, Florida, United States
- Northeast Georgia Cancer Care, Llc
Athens, Georgia, United States
- Dublin Hematology & Oncology Care
Dublin, Georgia, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2016
- Last update posted
- 11 Jul 2022
- Registered enrollment
- 154
- Registry id
- NCT01034631
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.